I honestly don't pay too much attention to silly movements in the share price, unfortunately the stock doesn't have strong daily liquidity which makes it tricky when holders need or want to sell. Pre-revenue stocks are not attracting investors at the moment, but things will change in the next 12 months for EMV.
Management is hitting milestones, no need for a CR for a fair amount of time and tech working at a level better than expected, so just need to wait.
Ann: Stage 3 Recuitment Achieved & FDA Engagement Underway, page-17
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.99 |
Change
-0.040(1.97%) |
Mkt cap ! $169.9M | |||
| Open | High | Low | Value | Volume |
| $2.00 | $2.01 | $1.99 | $7.404K | 3.701K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2953 | $1.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.03 | 799 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| EMV (ASX) Chart |